Trial intelligence / Profile preview

Intravenous magnesium sulfate versus lidocaine for prevention of laryngospasm after adenotonsillectomy in children

IRCT20120915010841N22Phase 2Completed

Sponsor
Hamadan University of Medical Sciences
Start
Nov 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in laryngismus and postoperative pain comparing Magnesium sulfate with Lidocaine (2 arms). Primary endpoint: Laryngospasm. Started Nov 2019; status: completed.

02

Drugs

magnesium sulfatelidocaine
03

Conditions

laryngismuspostoperative pain

Beyond the preview

Go deeper on IRCT20120915010841N22.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20120915010841N22.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call